Early Commercial Considerations
Strategic advice for early-stage, pre-clinical and clinical-stage Biotech companies on matters related to starting-up the business (ie. overall corporate strategy, investors presentations, IP protection, development, global regulatory strategy, and commercialization timelines).
Global Footprint Design & Go-To-Market Strategy
Customized effective decision-making tools to help Biotech companies build a solid geographical footprint and develop the best strategy for the successful global launch of specialized drugs or rare disease/orphan drugs. Advice on country prioritization, go-to-market models, launch cadence, pricing and market access considerations, etc.
Local Structure and/or Strategic Alliances
Establishment of a direct presence (subsidiary set-up, local structure design) or a solid partnership if not going it alone. Identification and evaluation of potential partners (ie. licensees, full-service distributors, 3PLs). Development of shop-around decks and presentations. Structuring of deal terms and economics. Initial alliance management.